Skip to main content

Publications search

Found 37173 matches. Displaying 4291-4300
Malik S, Roeder RG
Show All Authors

Mediator: A Drawbridge across the Enhancer-Promoter Divide

MOLECULAR CELL 2016 NOV 3; 64(3):433-434
Two papers in this issue of Molecular Cell provide insights into how the multisubunit Mediator coactivator complex dynamically links enhancer-bound activators to the RNA polymerase II machinery at the core promoter.
Litvin Y, Turner CA, Rios MB, Maras PM, Chaudhury S, Baker MR, Blandino P, Watson SJ, Akil H, McEwen B
Show All Authors

Fibroblast growth factor 2 alters the oxytocin receptor in a developmental model of anxiety-like behavior in male rat pups

HORMONES AND BEHAVIOR 2016 NOV; 86(?):64-70
We aimed to determine the short-term effects of early-life stress in the form of maternal separation (MS) on anxiety-like behavior in male rat pups. In order to assess anxiety, we measured 40 kHz separation-induced ultrasonic vocalizations (USV) on postnatal day (PND) 11. We further aimed to evaluate the potential involvement of two neurochemical systems known to regulate social and anxiety-like behaviors throughout life: oxytocin (OT) and fibroblast growth factor 2 (FGF2). For these purposes, we tested the effects of neonatal administration (on PND1) of an acute dose of FGF2 on USV and its potential interaction with MS. In addition, we validated the anxiolytic effects of OT and measured oxytocin receptor (OTR) gene expression, binding and epigenetic regulation via histone acetylation. Our results show that MS potentiated USV while acute administration of OT and FGF2 attenuated them. Further, we found that both FGF2 and MS increased OTR gene expression and the association of acH3K14 with the OTR promoter in the bed nucleus of the stria terminalis (BNST). Comparable changes, though not as pronounced, were also found for the central amygdala (CeA). Our findings suggest that FGF2 may exert its anxiolytic effects in male MS rats by a compensatory increase in the acetylation of the OTR promoter to overcome reduced OT levels in the BNST. (C) 2016 Published by Elsevier Inc.
Esaki H, Czarnowicki T, Gonzalez J, Oliva M, Talasila S, Haugh I, Rodriguez G, Becker L, Krueger JG, Guttman-Yassky E, Paller AS
Show All Authors

Accelerated T-cell activation and differentiation of polar subsets characterizes early atopic dermatitis development

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2016 NOV; 138(5):1473-+
Lin CS, Tsai YH, Chang CJ, Tseng SF, Wu TR, Lu CC, Wu TS, Lu JJ, Horng JT, Martel J, Ojcius DM, Lai HC, Young JD
Show All Authors

An iron detection system determines bacterial swarming initiation and biofilm formation

SCIENTIFIC REPORTS 2016 NOV 15; 6(?):? Article 36747
Iron availability affects swarming and biofilm formation in various bacterial species. However, how bacteria sense iron and coordinate swarming and biofilm formation remains unclear. Using Serratia marcescens as a model organism, we identify here a stage-specific iron-regulatory machinery comprising a two-component system (TCS) and the TCS-regulated iron chelator 2-isocyano-6,7-dihydroxycoumarin (ICDH-Coumarin) that directly senses and modulates environmental ferric iron (Fe3+) availability to determine swarming initiation and biofilm formation. We demonstrate that the two-component system RssA-RssB (RssAB) directly senses environmental ferric iron (Fe3+) and transcriptionally modulates biosynthesis of flagella and the iron chelator ICDH-Coumarin whose production requires the pvc cluster. Addition of Fe3+, or loss of ICDH-Coumarin due to pvc deletion results in prolonged Rsssignaling activation, leading to delayed swarming initiation and increased biofilm formation. We further show that ICDH-Coumarin is able to chelate Fe3+ to switch off Rsssignaling, triggering swarming initiation and biofilm reduction. Our findings reveal a novel cellular system that senses iron levels to regulate bacterial surface lifestyle.
Bayliss J, Mukherjee P, Lu C, Jain SU, Chung C, Martinez D, Sabari B, Margol AS, Panwalkar P, Parolia A, Pekmezci M, McEachin RC, Cieslik M, Tamrazi B, Garcia BA, La Rocca G, Santi M, Lewis PW, Hawkins C, Melnick A, Allis CD, Thompson CB, Chinnaiyan AM, Judkins AR, Venneti S
Show All Authors

Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas

Science Translational Medicine 2016 NOV 23; 8(366):? Article 366ra161
Childhood posterior fossa (PF) ependymomas cause substantial morbidity and mortality. These tumors lack recurrent genetic mutations, but a subset of these ependymomas exhibits CpG island (CpGi) hypermethylation [PF group A (PFA)], implicating epigenetic alterations in their pathogenesis. Further, histological grade does not reliably predict prognosis, highlighting the importance of developing more robust prognostic markers. We discovered global H3K27me3 reduction in a subset of these tumors (PF-ve ependymomas) analogous to H3K27M mutant gliomas. PF-ve tumors exhibited many clinical and biological similarities with PFA ependymomas. Genomic H3K27me3 distribution showed an inverse relationship with CpGi methylation, suggesting that CpGi hypermethylation drives low H3K27me3 in PF-ve ependymomas. Despite CpGi hypermethylation and global H3K27me3 reduction, these tumors showed DNA hypomethylation in the rest of the genome and exhibited increased H3K27me3 genomic enrichment at limited genomic loci similar to H3K27M mutant gliomas. Combined integrative analysis of PF-ve ependymomas with H3K27M gliomas uncovered common epigenetic deregulation of select factors that control radial glial biology, and PF radial glia in early human development exhibited reduced H3K27me3. Finally, H3K27me3 immunostaining served as a biomarker of poor prognosis and delineated radiologically invasive tumors, suggesting that reduced H3K27me3 may be a prognostic indicator in PF ependymomas.
Akiba K, Akbiyik M, Albrow M, Arneodo M, Avati V, Baechler J, Baillie OV, Bartalini P, Bartels J, Baur S, Baus C, Beaumont W, Behrens U, Berge D, Berretti M, Bossini E, Boussarie R, Brodsky S, Broz M, Bruschi M, Bussey P, Byczynski W, Noris JCC, Villar EC, Campbell A, Caporale F, Carvalho W, Chachamis G, Chapon E, Cheshkov C, Chwastowski J, Ciesielski R, Chinellato D, Cisek A, Coco V, Collins P, Contreras JG, Cox B, Damiao DD, Davis P, Deile M, D'Enterria D, Druzhkin D, Ducloue B, Dumps R, Dzhelyadin R, Dziurdzia P, Eliachevitch M, Fassnacht P, Ferro F, Fichet S, Figueiredo D, Field B, Finogeev D, Fiore R, Forshaw J, Medina AG, Gallinaro M, Granik A, von Gersdorff G, Giani S, Golec-Biernat K, Goncalves VP, Gottlicher P, Goulianos K, Grosslord JY, Harland-Lang LA, Van Haevermaet H, Hentschinski M, Engel R, Corral GH, Hollar J, Huertas L, Johnson D, Katkov I, Kepka O, Khakzad M, Kheyn L, Khachatryan V, Khoze VA, Klein S, van Klundert M, Krauss F, Kurepin A, Kurepin N, Kutak K, Kuznetsova E, Latino G, Lebiedowicz P, Lenzi B, Lewandowska E, Liu S, Luszczak A, Luszczak M, Madrigal JD, Mangano M, Marcone Z, Marquet C, Martin AD, Martin T, Hernandez MIM, Martins C, Mayer C, Mc Nulty R, Van Mechelen P, Macula R, da Costa EM, Mertzimekis T, Mesropian C, Mieskolainen M, Minafra N, Monzon IL, Mundim L, Murdaca B, Murray M, Niewiadowski H, Nystrand J, de Oliveira EG, Orava R, Ostapchenko S, Osterberg K, Panagiotou A, Papa A, Pasechnik R, Peitzmann T, Moreno LAP, Pierog T, Pinfold J, Poghosyan M, Pol ME, Prado W, Popov V, Rangel M, Reshetin A, Revol JP, Rijssenbeek M, Rodriguez M, Roland B, Royon C, Ruspa M, Ryskin M, Vera AS, Safronov G, Sako T, Schindler H, Salek D, Safarik K, Saimpert M, Santoro A, Schicker R, Seger J, Sen S, Shabanov A, Schafer W, Da Silveira GG, Skands P, Soluk R, van Spilbeeck A, Staszewski R, Stevenson S, Stirling WJ, Strikman M, Szczurek A, Szymanowski L, Takaki JDT, Tasevsky M, Taesoo K, Thomas C, Torres SR, Tricomi A, Trzebinski M, Tsybychev D, Turini N, Ulrich R, Usenko E, Varela J, Lo Vetere M, Tello AV, Pereira AV, Volyanskyy D, Wallon S, Wilkinson G, Wohrmann H, Zapp KC, Zoccarato Y
Show All Authors

LHC forward physics

JOURNAL OF PHYSICS G-NUCLEAR AND PARTICLE PHYSICS 2016 NOV; 43(11):? Article 110201
Hammer MJ, Eckardt P, Barton-Burke M
Show All Authors

Informed Consent: A Clinical Trials Perspective

ONCOLOGY NURSING FORUM 2016 NOV; 43(6):694-696
The primary goal of the thousands of registered trials in cancer research is to extend survival. With evaluation of efficacy, safety, and tolerability, healthcare providers must ensure that the principles described in the Belmont Report are upheld and that patients are truly informed when signing a consent form. In this article, two cases are highlighted, and reasons for participating in clinical trials are discussed. Challenges, such as healthcare literacy, patients' dedication to their healthcare providers, and choosing between multiple trials, are also explored.
Cohen JE
Show All Authors

Statistics of Primes (and Probably Twin Primes) Satisfy Taylor's Law from Ecology

AMERICAN STATISTICIAN 2016 NOV; 70(4):399-404
Taylor's law, which originated in ecology, states that, in sets of measurements of population density, the sample variance is approximately proportional to a power of the sample mean. Taylor's law has been verified for many species ranging from bacterial to human. Here, we show that the variance V(x) and the mean M(x) of the primes not exceeding a real number x obey Taylor's law asymptotically for large x. Specifically, V(x) similar to (1/3)(M(x))(2) as x -> infinity. This apparently new fact about primes shows that Taylor's law may arise in the absence of biological processes, and that patterns discovered in biological data can suggest novel questions in numbertheory. If the Hardy-Littlewood twin primes conjecture is true, then the identical Taylor's law holds also for twin primes. Taylor's law holds in both instances because the primes (and the twin primes, given the conjecture) not exceeding x are asymptotically uniformly distributed on the integers in [2,x]. Hence, asymptotically M(x) similar to x/2, V(x) similar to x(2)/12. Higher-order moments of the primes (twin primes) not exceeding x satisfy a generalized Taylor's law. The 11,078,937 primes and 813,371 twin primes not exceeding 2 x 10(8) illustrate these results.
Ulveling D, Le Clerc S, Cobat A, Labib T, Noirel J, Laville V, Coulonges C, Carpentier W, Nalpas B, Heim MH, Poynard T, Cerny A, Pol S, Bochud PY, Dabis F, Theodorou I, Levy Y, Salmon D, Abel L, Dominguez S, Zagury JF
Show All Authors

A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients

HEPATOLOGY 2016 NOV; 64(5):1462-1472
There is growing evidence that human genetic variants contribute to liver fibrosis in subjects with hepatitis C virus (HCV) monoinfection, but this aspect has been little investigated in patients coinfected with HCV and human immunodeficiency virus (HIV). We performed the first genome-wide association study of liver fibrosis progression in patients coinfected with HCV and HIV, using the well-characterized French National Agency for Research on AIDS and Viral Hepatitis CO13 HEPAVIH cohort. Liver fibrosis was assessed by elastography (FibroScan), providing a quantitative fibrosis score. After quality control, a genome-wide association study was conducted on 289 Caucasian patients, for a total of 8,426,597 genotyped (Illumina Omni2.5 BeadChip) or reliably imputed single-nucleotide polymorphisms. Single-nucleotide polymorphisms with P values <10(-6) were investigated in two independent replication cohorts of European patients infected with HCV alone. Two signals of genome-wide significance (P < 5 x 10(-8)) were obtained. The first, on chromosome 3p25 and corresponding to rs61183828 (P = 3.8 x 10(-9)), was replicated in the two independent cohorts of patients with HCV monoinfection. The cluster of single-nucleotide polymorphisms in linkage disequilibrium with rs61183828 was located close to two genes involved in mechanisms affecting both cell signaling and cell structure (CAV3) or HCV replication (RAD18). The second signal, obtained with rs11790131 (P = 9.3 x 10(-9)) on chromosome region 9p22, was not replicated. Conclusion: This genome-wide association study identified a new locus associated with liver fibrosis severity in patients with HIV/HCV coinfection, on chromosome 3p25, a finding that was replicated in patients with HCV monoinfection; these results provide new relevant hypotheses for the pathogenesis of liver fibrosis in patients with HIV/HCV coinfection that may help define new targets for drug development or new prognostic tests, to improve patient care. (Hepatology 2016;64:1462-1472)
Ambrus A, Wang JJ, Mizsei R, Zambo Z, Torocsik B, Jordan F, Adam-Vizi V
Show All Authors

Structural alterations induced by ten disease-causing mutations of human dihydrolipoamide dehydrogenase analyzed by hydrogen/deuterium-exchange mass spectrometry: Implications for the structural basis of E3 deficiency

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 2016 NOV; 1862(11):2098-2109
Pathogenic amino acid substitutions of the common E3 component (hE3) of the human alpha-ketoglutarate dehydrogenase and the pyruvate dehydrogenase complexes lead to severe metabolic diseases (E3 deficiency), which usually manifest themselves in cardiological and/or neurological symptoms and often cause premature death. To date, 14 disease-causing amino acid substitutions of the hE3 component have been reported in the clinical literature. None of the pathogenic protein variants has lent itself to high-resolution structure elucidation by X-ray or NMR. Hence, the structural alterations of the hE3 protein caused by the disease-causing mutations and leading to dysfunction, including the enhanced generation of reactive oxygen species by selected disease-causing variants, could only be speculated. Here we report results of an examination of the effects on the protein structure of ten pathogenic mutations of hE3 using hydrogen/deuterium-exchange mass spectrometry (HDX-MS), a new and state-of-the-art approach of solution structure elucidation. On the basis of the results, putative structural and mechanistic conclusions were drawn regarding the molecular pathogenesis of each disease-causing hE3 mutation addressed in this study. (C) 2016 Elsevier B.V. All rights reserved.